Liminatus Pharma, Inc.
LIMN
$9.02
$0.212.38%
NASDAQ
| 03/31/2025 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -94.01% | |||
| Total Receivables | -- | 74.07% | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -- | 81.82% | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | 4.29% | |||
| Total Current Assets | -- | 15.44% | |||
|
|
|||||
| Total Current Assets | -- | 15.44% | |||
| Net Property, Plant & Equipment | -- | 0.00% | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -- | -- | |||
| Total Assets | -- | 15.43% | |||
|
|
|||||
| Total Accounts Payable | -- | 0.64% | |||
| Total Accrued Expenses | -99.96% | 103.96% | |||
| Short-term Debt | -- | 7.48% | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | -- | -- | |||
| Total Finance Division Other Current Liabilities | -- | 1.03% | |||
| Total Other Current Liabilities | -- | 1.03% | |||
| Total Current Liabilities | -100.00% | 11.64% | |||
|
|
|||||
| Total Current Liabilities | -100.00% | 11.64% | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | 7.48% | |||
| Capital Leases | -- | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | -100.00% | 11.64% | |||
|
|
|||||
| Common Stock & APIC | -100.00% | 0.00% | |||
| Retained Earnings | 100.00% | -6.98% | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 99.99% | -11.11% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | -- | |||
|
|
|||||
| Total Common Equity | 99.99% | -11.11% | |||
| Total Preferred Equity | -- | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 99.99% | -11.11% | |||
|
|
|||||